Governmental organizations and the pharma industry are of the same mind in South Korea when it comes to the urgency of the need to fight COVID-19. AsiaNewsNetwork
The participants acknowledged that while the likes of GC Pharma and SK Biosciene were intent on researching for vaccines and treatments, there are bound to be shortfalls. With expert anticipations suggesting there will be recurrences of pandemics of this scale in the future, KPBMA asserted this is an issue not for individual companies to tackle separately.
The association will therefore seek to create a joint venture participated by all members, or establish a joint fund taking after Europe’s Innovative Medicines Initiative. On the same day, ministries of science, drug, health, trade, agriculture and marine gathered for the seventh special committee on biologics development to increase research and development investments for medicine in face of the pandemic.
The committee discussed assigning 624 billion won budget for vaccine development and 1.5 trillion won to enhance medicinal infrastructure encompassing artificial intelligence.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Remakes of S. Korean TV shows gain popularity in US, EuropeSEOUL — In a reality singing competition television series on Fox, celebrities in extravagant costumes and face masks perform a cover of a famous song, while the audience and panelists who
Read more »
Korean Air sells Jeju housing complex for employees amid liquidity crisisSEOUL — Korean Air, the main cash cow for the transport and logistics company Hanjin Group, has sold a housing complex it built for its employees on Jeju Island, industry sources said Wednesday.
Read more »
Seoul plays down report on North Korean leader's healthSouth Korea downplays a report Tuesday, April 21, that the North's leader Kim Jong Un was being treated after surgery, as speculation mounts over his absence from a key anniversary. Full story:
Read more »